期刊文献+

肥厚型心肌病心肌组织TGFβ异构体表达及意义 被引量:2

EXPRESSION AND ITS SIGNIFICANCE OF TGFβ IN HYPERTROPHIC CARDIOMYOPATHY
下载PDF
导出
摘要 目的研究转化生长因子β(TGFβ)异构体在肥厚型心肌病病人心肌组织中的表达,以探讨TGFβ异构体与肥厚型心肌病心肌纤维化的关系,为法医学诊断肥厚型心肌病提供客观指标。方法采用免疫组化方法,检测TGFβ1、TGFβ2、TGFβ3在56例肥厚型心肌病病人及18例对照组心肌组织中的表达水平,并使用图像分析系统进行结果判断。结果TGFβ1、TGFβ2、TGFβ3在肥厚型心肌病病人心肌中的表达均高于对照者,差异有显著性(t=20.18~28.93,P〈0.05)。结论TFGβ异构体在肥厚型心肌病心肌纤维化的发生发展中具有重要作用,是法医诊断肥厚型心肌病的客观指标。 Objective To study the expression of transforming growth factor-β (TGFβ) isomer in cardiac muscle of pa tients with hypertrophic cardiomyopathy (HC), explore the relationship between TGFβ3 isomer and myocardial fibrosis in HC, and provide objective indicators for forensic diagnosis of the disease. Methods Employing immunohistochemical method, expressions of TGFβ1, TGFβ2 and TGFβ3 in tissue of cardiac muscle of 56 HC patients and 18 controls were detected, the results were judged using image analysis system. ; Results The expressions of TGFβ1, .TGFβ2 and TGFβ3 in HC patients were higher than healthy controls, the difference were statistically significant (t=20.18--28.93,P〈0.05). Conclusion TGFβ isomer plays an important role in the occurrence and development of myocardial fibrosis in hypertrophic eardiomyopathy, which is an objective indicator for medicolegal identification of this condition.
出处 《齐鲁医学杂志》 2015年第3期287-288,291,共3页 Medical Journal of Qilu
基金 青岛市科技计划基础研究项目(13-1-4-141-jch)
关键词 心肌病 肥厚性 转化生长因子Β 心肌纤维化 cardiomyopathy, hypertrophic transforming growth factor beta~ myocardial fibrosis
  • 相关文献

参考文献13

  • 1HORITA Y, SHIMIZU M, SUGIHARA N, et al. An autop sy case of hypertrophic cardiomyopathy showing dilated cardio myopathy-like features by serial ventrieulography[J]. Japanese Journal of Medicine, 1991,29(4) :448-453.
  • 2UNVERFERTH D V, BAKER P B, PEARCE L I, et al. Re- gional myocyte hypertrophy and increased interstitial myocar dial fibrosis in hypertrophic eardiomyopathy[J]. The American Journal of Cardiology, 1987,59(9) :932-936.
  • 3SCHUPPAN D, KODA M, BAUER M, et al. Fibrosis of [i ver, pancreas and intestine: common mechanisms and clear targets[J]. Acta Gastro-Enterologica Belgica, 2001,63 (4) 366-370.
  • 4SCHILLER M, JAVELAUD D, MAUVIEL A. TGF-beta-in- duced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing[J]. Journal of Dermatological Science, 2004,35(2): 83 -92.
  • 5BONEWALD L F. Regulation and regulatory activities of transforming growth factor beta[J]. Critical Reviews in Eu- karyotic Gene Expression, 1999,9(1) :33-34.
  • 6ELLIMS A H, ILES L M, LING L H, et al. Diffuse myocar- dial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dys{unetion[J]. Journal of Cardiovas eular Magnetic Resonance Official Journal of the Society {or Cardiovascular Magnetic Resonance, 2012,14 - 76.
  • 7崔世超,于文成,刘娴娴,张杰.气道平滑肌细胞TGF-β_1表达与COPD气道重塑关系[J].青岛大学医学院学报,2012,48(1):57-58. 被引量:20
  • 8ROSENKRANZ S, FLESCH M, AMANN K, et al. Altera- tions of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta ( 1 ) [J ]. American Journal of Physiology-Heart and Circulatory Physiology, 2002,283(3) ; H1253-H1262.
  • 9张少燕,刘霞,王笑峰,王云,罗兵.TGF-β1参与调控LMP1介导信号转导通路的研究[J].青岛大学医学院学报,2013,49(5):386-389. 被引量:2
  • 10OBATA H, KABURAKI T, KATO M, et al. Expression of TGF-beta type I and type lI receptors in rat eyes[J]. Cur- rent Eye Research, 1996,15(3) :335-340.

二级参考文献21

  • 1张明生,朱宝玉.慢性阻塞性肺疾病患者免疫功能和运动耐量的关系[J].临床内科杂志,2007,24(4):282-283. 被引量:5
  • 2RABE K F,HURD S,ANZUETO A,et al.Global strategyfor the diagnosis,management,and prevention of chronic ob-structive pulmonary disease:GOLD executive summary[J].Am J Respir Crit Care Med,2007,176:532-555.
  • 3中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南.中华结核和呼吸病杂志,2007,30(11):8-17.
  • 4ITO M,HANAOKA M,DROMA Y,et al.The associationof transforming growth factor betal gene polymorphisms withthe emphysema phenotype of COPD in Japanese[J].InternMed,2008,47:1387-1394.
  • 5THOMPSON M P, KURZROCK R. Epstein-Barr virus and cancer[J]. Clin Cancer Res, 2004,10 (3) :803-82l.
  • 6KAWANISHI M Expression of Epstein-Barr virus latent mem?brane protein 1 protectsJ urkat T cells from apoptosis induced by serum deprivation[J]. Virology, 1997,228 (2) :244-250.
  • 7KAYE K M, IZUMI K M, KIEFF E. Epstein-Barr virus latent membrane protein 1 is essential for B-Iymphocyte growth transfor?mation[J]. Proc Natl Acad Sci USA, 1993,90: 9150-9154.
  • 8TANAKA A, MATSUDA H. IgE cross linkage of Fcepsilon re?ceptor 1 induces both production and activation of matrix metallo?proteinase-S in mast cellsO]' Cell Immunol , 2004,228(1) :66-75.
  • 9YOSHIZAKI T, SA TO H, MURONO S, et al. Matrix met?alloproteinase 9 is induced by the Epstein-Barr virus BZLFI transactivatorj]]. Clin Exp Metastasis, 1999,17(5) :431-436.
  • 10HORIKAWA T, YOSHIZAKI T, SHEEN TS, et al. Associ?ation of latent membrane protein 1 and matrix metalloprotei?nase 9 with metastasis in nasopharyngeal carcinoma[]]. Can?cer, 2000,89(4): 715-723.

共引文献20

同被引文献31

  • 1YAMAGUCHI Y, MANN D M, RUOSLAHTI E. Negative regulation of transforming growth factor-beta by the proteo- glycan decorin[J]. Nature, 1990,346(6281) :281-284.
  • 2BAGHY K, DEZSO K, LA.SZLO V, et al. Ablation of the deeorin gene enhances experimental hepatic fibrosis and im- pairs hepatic healing in mice[-J. Laboratory Investigation: a Journal of Technical Methods and Pathology, 2011,91 (3) 439-451.
  • 3MOHAN R R, TOVEY J C, GUPTA R, et al. Decorin biolo- gy, expression, function and therapy in the cornea[J]. Current Molecular Medicine, 2011,11(2) : 110-128.
  • 4FUKUSHIMA K, BADLANI N, USAS A, et al. The use of an antifibrosis agent to improve muscle recovery after lacera- tion[J]. The American Journal of Sports Medicine, 2001,29 (4) :394-402.
  • 5KHAN G A, GIRISH G V, LALA Neena, et al. Decorin is a novel VEGFR-2-binding antagonist for the human extravillous trophoblast[J]. Molecular Endocrinology (Baltimore, Md.),2011,25(8):1431-1443.
  • 6AKMAN T, TEFEKLI A, ARMAGAN A, et al. Decorin treatment in Peyronie's disease[J].Andrologia, 2013,45: 101- 106.
  • 7AHMED Z, BANSAL D, TIZZARD K, et al. Decorin blocks scarring and cystic cavitation in acute and induces scar dissolu- tion in chronic spinal cord wounds[J]. Neurobiology of Di- sease, 2014,64:163-176.
  • 8BI X L, YANG W C. Biological functions of decorin in cancer [J]. Chinese Journal of Cancer, 2013,.32(5) :266-269.
  • 9CICILIOT S, SCHIAFFINO S. Regeneration of mammalian skeletal muscle. Basic mechanisms and clinical implications[J]. Current Pharmaceutical Design, 2010,16(8):906-914.
  • 10MANN C J, PERDIGUERO E, KHARRAZ Y, et al. Aber- rant repair and fibrosis development in skeletal muscle [J]. Skeletal Muscle, 2011,1(1) :21.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部